Liu JF, Colombo N, Oza AM, Frenel JS, et al. ADAGIO: A Phase IIb, Open-Label, Single-Arm, Multicenter Study Assessing the Efficacy and Safety of Adavosertib (AZD1775) as Treatment for Recurrent or Persistent Uterine Serous Carcinoma. J Clin Oncol 2025;43:2897-2907.
PMID: 40262070